Michael D. Davis

Physiatry

11301 Wilshire Blvd
Los Angeles, CA 90073

Last Updated: 11/08/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2 publications

Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of VK-2019, a selective EBNA1 inhibitor.

Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of VK-2019, a selective EBNA1 inhibitor.

Journal: Biomedical chromatography : BMC

Published: August 26, 2023

Challenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experience.

Challenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experience.

Journal: PloS one

Published: February 04, 2014

Showing 1-2 of 2

Last Updated: 11/08/2026